Week 3 | A Veterinary Clinical Perspective
Introduction to Psychedelic Veterinary Medicine
A Veterinary Clinical Perspective
Week 3 | July 26th 2024
Introduction to Psychedelic Harm Reduction - A Veterinary Clinical Perspective
This session delves into harm reduction strategies specifically within veterinary clinical settings, focusing on the potential impacts of psychedelics on animals as veterinary patients.
We explore the impact of psychedelic substances on animals in a clinical setting. This talk covers various psychedelic substances, including amphetamines, MDMA, LSD, and psilocybin, discussing their clinical signs of toxicity, diagnosis, and treatment approaches.
We emphasize the importance of understanding these substances' effects on animal health and safety to better manage accidental ingestions and improve veterinary care. This discussion provides animal health professionals with practical guidelines for managing cases of accidental ingestion and ensuring the safety and well-being of animals.
Week 3’s Topics:
Understanding and managing psychedelic exposure in animals
Developing clinical protocols and best practices
Training and capacity building for veterinary professionals
Educating pet owners and addressing legal and ethical considerations
Week 3’s Resources:
Harm Reduction Education & Product Safety - Veterinary Cannabis
Emergency Management and Treatment of the Poisoned Small Animal Patient
General Management of the Intoxicated Patient: What Is the Evidence?
Watch Week3 Recorded Lecture here.
$25 registration
30min lecture
valid for 0.5 hr CE for VCCounselor renewal requirements